Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026)
Mangoceuticals (MGRX) posted Income from Non-Controlling Interests of -$1533.0 for Q1 2026, down 878.17% sequentially from $197.0 in Q4 2025, and down 1464.29% YoY from $112.37 in Q1 2025.
Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Mangoceuticals has reported Income from Non-Controlling Interests for 4 years, with the latest figure at -$1533.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 1464.29% year-over-year to -$1533.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1896.0 (down 65.88% YoY) and the FY2025 annual result came in at -$461.0, up 57.35% from the prior year.
- Income from Non-Controlling Interests declined to -$1533.0 in Q1 2026 per MGRX's latest filing, from $197.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $197.0 in Q4 2025 and troughed at -$1.8 million in Q3 2023.
- A 4-year average of -$180253.5 and a median of -$292.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2025 and 2026: Income from Non-Controlling Interests surged 180.74% in 2025, then slumped 1464.29% in 2026.
- Over 4 years, Income from Non-Controlling Interests stood at -$1.8 million in 2023, then soared by 99.99% to -$244.0 in 2024, then jumped by 180.74% to $197.0 in 2025, then sank by 878.17% to -$1533.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$1533.0, $197.0, and -$558.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -81,000.00 |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | -278.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -278.00 |
| Mar 31, 2026 | -1,533.00 |
| Dec 31, 2025 | 197.00 |
| Sep 30, 2025 | -558.00 |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | -98.00 |
| Dec 31, 2024 | -244.00 |
| Sep 30, 2024 | -461.00 |
| Jun 30, 2024 | -340.00 |
| Mar 31, 2024 | -36.00 |
| Sep 30, 2023 | -1.80 Mn |